News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Rahul Banerjee: Great work by Rami Kotb et al. on Isatuximab in Multiple Myeloma
Rahul Banerjee and Rami Kobt
Feb 6, 2025, 15:59

Rahul Banerjee: Great work by Rami Kotb et al. on Isatuximab in Multiple Myeloma

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared an article Rami Kobt and colleagues authored on X:

“Nice to see in CLML – great work by our Canadian colleagues Kotb et al! After 2 cycles of isatuximab in Multiple Myeloma, move to 30-min infusions. No montelukast needed, albeit they did keep dex. 30 < 75 min, so less time toxicity for pts and more time for nurses!”

Real-World Safety and Tolerability of Rapid, 30-minutes, Intravenous Isatuximab in Patients with Multiple Myeloma.

Authored: Rami Kotb et al.

Rahul Banerjee

cancer Emily Rimmer Ivan Landego Jayne Kasian Leonard Minuk Marc Geirnaert OncoDaily Oncology Rahul Banerjee Rami Kotb Vi Dao
Special Coverage
Voices
Sep 3, 2025, 11:09
ALCSI Podcast Series: Dr. Aurora Lucas
Science
Sep 3, 2025, 10:50
Jordi Remon: PECATI Trial - Lenvatinib Plus Pembrolizumab in Metastatic B3-Thymoma and Thymic Carcinoma
Voices
Sep 3, 2025, 10:35
From Shorter Treatments to Personalised Strategies - ESTRO
Voices
Sep 3, 2025, 10:27
Gerry Hanna: 20 Years of Progress and Future Goals in Cancer Care Across Europe
Science
Sep 3, 2025, 10:22
Pierre Blanchard: Another Proof That Metastasis-Directed Therapy Improves Outcomes
Voices
Sep 3, 2025, 10:18
Powerful Actions Driving Change in Childhood Cancer Care - SIOP
Voices
Sep 3, 2025, 10:08
Rafael Fonseca: Classifying Myeloma Treatments as Curative Versus Control Ones
Insight
Sep 3, 2025, 10:07
Oncia Community is hosting a Free Webinar on the Role of Nutrition in Cancer Care
Science
Sep 3, 2025, 10:07
C. Jillian Tsai: Comprehensive Guidelines in Nasopharyngeal Carcinoma Radiotherapy
Insight
Sep 3, 2025, 10:03
Miguel Bronchud: Key Takeaways from Kerstin N. Vokinger on Oncology Drug Innovation and Regulatory Strategy
Insight
Sep 3, 2025, 09:59
Rishabh Jain: FGFR1 Joins the Club of High-Risk CRC Alterations
Voices
Sep 3, 2025, 09:57
Joshua Omale: Why Gold is the Color of Childhood Cancer Awareness?